研究人员为胰腺癌开发新的血液测试,精确检测了71%的病例。 Researchers develop a new blood test for pancreatic cancer that accurately detects 71% of cases.

来自Van Andel研究所和匹兹堡大学的科学家开发了一种新的胰腺癌血液测试,正确识别了71%的癌症样本,而按目前的方法,这一比例为44%。 Scientists from the Van Andel Institute and the University of Pittsburgh have developed a new blood test for pancreatic cancer that correctly identified 71% of cancer samples, compared to 44% by the current method. 该试验正在由商业实验室进行评估,有可能在高风险人群中早期发现胰腺癌,并监测治疗进展。 The test, which is being evaluated by a commercial lab, could potentially detect pancreatic cancer earlier in high-risk individuals and monitor treatment progress. 如果成功,在诊断和管理该疾病方面可以是一个重大改进。 If successful, it could be a significant improvement in diagnosing and managing the disease.